Latest News about ELDN
Recent news which mentions ELDN
   12 Health Care Stocks Moving In Tuesday's After-Market Session
   
  
  
  September 06, 2022
  From Benzinga
 
   Recap Of Monday's Biotech Catalysts - End Of the Day Summary
   
  
  
  August 01, 2022
  From Benzinga
 
   Daily Biotech Pulse: Celyad Resumes Colorectal Cancer Trial, Setback For Otonomy, AstraZeneca Halts Phase 3 Head, Neck Cancer Trial
   
  
  
  August 01, 2022
  From Benzinga
 From Benzinga
 From Benzinga
 From Benzinga
 From Benzinga
 
   88 Biggest Movers From Yesterday
   
  
  
  May 27, 2022
  From Benzinga
 
   The Daily Biotech Pulse: MEI Pharma Wilts On Adverse Regulatory Development, Decision Day For Zogenix, AN2 Therapeutics IPO
   
  
  
  March 25, 2022
  From Benzinga
 From Benzinga
 
   Earnings Scheduled For March 24, 2022
   
  
  
  March 24, 2022
  From Benzinga
 
   The Week Ahead In Biotech (March 20-26): Focus On Zogenix FDA Decision, Dermatology Conference Presentations & Earnings
   
  
  
  March 20, 2022
  From Benzinga
 
   12 Health Care Stocks Moving In Tuesday's After-Market Session
   
  
  
  January 04, 2022
  From Benzinga
 
   70 Biggest Movers From Friday
   
  
  
  November 15, 2021
  From Benzinga
 
   12 Health Care Stocks Moving In Friday's Intraday Session
   
  
  
  November 12, 2021
  From Benzinga
 
   12 Health Care Stocks Moving In Friday's Pre-Market Session
   
  
  
  November 12, 2021
  From Benzinga
 
   The Daily Biotech Pulse: J&J To Spin-off Consumer Health Business, AstraZeneca Earnings, Embattled Emergent To Buy Back Shares
   
  
  
  November 12, 2021
  From Benzinga
 
   The Daily Biotech Pulse: Eisai-Gilead Tout Positive Phase 2 Data For New Alzheimer's Treatment, Compugen Spikes On Bristol-Myers Investment, Vaxxinity Debuts
   
  
  
  November 11, 2021
  From Benzinga
 
   Earnings Scheduled For November 11, 2021
   
  
  
  November 11, 2021
  From Benzinga
 
   The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal
   
  
  
  October 06, 2021
  From Benzinga
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.